Approval · Notice of Compliance 4771 · 2004
MODURET: Notice of Compliance 4771
Issued June 21, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4771
- Date
- June 21, 2004
- Company
- Orbus Pharma Inc.Markham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Diuretic, antihypertensive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MODURET | 00487813 | Cancelled Post Market |
Medicinal ingredients
- AMILORIDE HYDROCHLORIDE 5 MG per TAB
- HYDROCHLOROTHIAZIDE 50 MG per TAB